trending Market Intelligence /marketintelligence/en/news-insights/trending/dyhnrmkbkuz24qfpuzx9wa2 content esgSubNav
In This List

Aeglea BioTherapeutics appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aeglea BioTherapeutics appoints director

Aeglea Biotherapeutics Inc. appointed Ivana Magovcevic-Liebisch as a director.

Magovcevic-Liebisch is the executive vice president and chief business officer of Ipsen SA, a global biopharmaceutical company.

Austin, Texas-based Aeglea Biotherapeutics is a biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.